The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone-Reference-Cited by-同舟云学术

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

Published:2014-02-06 Issue:9 Volume:16 Page:1263-1273
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Molenaar Remco J.,Verbaan Dagmar,Lamba Simona,Zanon Carlo,Jeuken Judith W.M.,Boots-Sprenger Sandra H.E.,Wesseling Pieter,Hulsebos Theo J.M.,Troost Dirk,van Tilborg Angela A.,Leenstra Sieger,Vandertop W. Peter,Bardelli Alberto,van Noorden Cornelis J.F.,Bleeker Fonnet E.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/16/9/1263/16855931/nou005.pdf

Reference75 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Genetic pathways to primary and secondary glioblastoma;Ohgaki;Am J Pathol,2007

4. Recent advances in the molecular understanding of glioblastoma;Bleeker;J Neurooncol,2012

5. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review;International Journal of Molecular Sciences;2024-09-08

2. Genomic, epigenomic and transcriptomic landscape of glioblastoma;Metabolic Brain Disease;2024-08-24

3. Risk Factors of Distant Recurrence and Dissemination of IDH Wild-Type Glioblastoma: A Single-Center Study and Meta-Analysis;Cancers;2024-08-18

4. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?;Neuro-Oncology;2024-06-24

5. Genetic Prognostic Factors in Adult Diffuse Gliomas: A 10-Year Experience at a Single Institution;Cancers;2024-06-01